Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
1700012G 19Rik | |
AK012010 |
10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610311O05 product:hypothetical HAD-like structure containing protein, full insert sequence [AK012010] |
KLA | .45 |
.39 |
.37 |
.43 |
.48 |
.64 |
.62 |
| ATP | .93 |
1.05 |
.88 |
.90 |
.63 |
.67 |
.56 |
| KLA/ATP | .43 |
.42 |
.42 |
.46 |
.49 |
.50 |
.37 |
|
1700012G 19Rik | |
NM_025954 |
RIKEN cDNA 1700012G19 gene (1700012G19Rik), mRNA [NM_025954] |
KLA | .34 |
.35 |
.28 |
.34 |
.42 |
.59 |
.70 |
| ATP | .92 |
.91 |
.88 |
.79 |
.70 |
1.27 |
.92 |
| KLA/ATP | .35 |
.33 |
.34 |
.32 |
.47 |
.80 |
.66 |
|
Acat1 | |
NM_144784 |
acetyl-Coenzyme A acetyltransferase 1 (Acat1), nuclear gene encoding mitochondrial protein, mRNA [NM_144784] |
KLA | 1.04 |
.99 |
.95 |
.99 |
.81 |
.83 |
.51 |
| ATP | .89 |
.88 |
1.21 |
.99 |
.67 |
.36 |
.47 |
| KLA/ATP | .86 |
.97 |
1.18 |
.90 |
.64 |
.42 |
.35 |
|
Acat2 | |
NM_009338 |
acetyl-Coenzyme A acetyltransferase 2 (Acat2), mRNA [NM_009338] |
KLA | 1.14 |
1.13 |
1.22 |
1.29 |
1.10 |
.93 |
.81 |
| ATP | 1.04 |
1.05 |
1.16 |
1.35 |
1.20 |
1.53 |
1.16 |
| KLA/ATP | 1.19 |
1.19 |
1.41 |
1.29 |
1.13 |
.92 |
.71 |
|
Aco1 | |
NM_007386 |
aconitase 1 (Aco1), mRNA [NM_007386] |
KLA | .82 |
.85 |
.80 |
.78 |
.73 |
.74 |
.84 |
| ATP | 1.02 |
1.07 |
1.04 |
.96 |
.95 |
.88 |
.83 |
| KLA/ATP | .83 |
.86 |
.81 |
.80 |
.76 |
.73 |
.62 |
|
Aco2 | |
AK029122 |
10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732494K09 product:hypothetical protein, full insert sequence [AK029122] |
KLA | 1.02 |
1.02 |
.99 |
.98 |
.97 |
1.04 |
.83 |
| ATP | .98 |
1.04 |
1.05 |
.95 |
.95 |
1.02 |
1.00 |
| KLA/ATP | .96 |
.95 |
1.00 |
1.04 |
1.06 |
1.03 |
.99 |
|
Aco2 | |
NM_080633 |
aconitase 2, mitochondrial (Aco2), nuclear gene encoding mitochondrial protein, mRNA [NM_080633] |
KLA | .93 |
.96 |
.97 |
.91 |
.97 |
.99 |
1.07 |
| ATP | 1.05 |
1.04 |
.98 |
.92 |
.90 |
.83 |
.99 |
| KLA/ATP | 1.01 |
1.06 |
.86 |
.89 |
.83 |
.93 |
.93 |
|
Afmid | |
NM_027827 |
arylformamidase (Afmid), mRNA [NM_027827] |
KLA | .85 |
.95 |
.89 |
.82 |
1.00 |
1.22 |
1.18 |
| ATP | 1.06 |
1.11 |
1.05 |
1.16 |
1.11 |
.95 |
.69 |
| KLA/ATP | .96 |
1.09 |
.95 |
1.06 |
1.00 |
.99 |
.91 |
|
Agxt | |
NM_016702 |
alanine-glyoxylate aminotransferase (Agxt), mRNA [NM_016702] |
KLA | 1.01 |
.95 |
.96 |
1.05 |
1.01 |
.98 |
.94 |
| ATP | .95 |
1.03 |
1.03 |
.99 |
.97 |
.96 |
1.05 |
| KLA/ATP | .94 |
.99 |
1.01 |
1.01 |
.96 |
.92 |
.96 |
|
Cat | |
NM_009804 |
catalase (Cat), mRNA [NM_009804] |
KLA | .63 |
.67 |
.67 |
.45 |
.36 |
.21 |
.43 |
| ATP | 1.10 |
1.25 |
.91 |
1.01 |
.78 |
1.28 |
.84 |
| KLA/ATP | .75 |
.69 |
.43 |
.59 |
.35 |
.72 |
.87 |
|
Cs | |
NM_026444 |
citrate synthase (Cs), nuclear gene encoding mitochondrial protein, mRNA [NM_026444] |
KLA | 1.09 |
1.07 |
1.04 |
1.05 |
1.08 |
1.15 |
1.14 |
| ATP | .91 |
.93 |
1.02 |
.90 |
.90 |
1.08 |
1.38 |
| KLA/ATP | .99 |
1.04 |
1.09 |
.98 |
.98 |
.90 |
1.13 |
|
Csl | |
NM_027945 |
citrate synthase like (Csl), mRNA [NM_027945] |
KLA | 1.41 |
1.32 |
1.35 |
1.51 |
1.61 |
1.39 |
1.58 |
| ATP | 1.17 |
1.15 |
.98 |
1.23 |
1.18 |
1.33 |
2.00 |
| KLA/ATP | 1.32 |
1.53 |
1.45 |
1.59 |
1.13 |
1.14 |
1.77 |
|
Gcsh | |
NM_026572 |
glycine cleavage system protein H (aminomethyl carrier) (Gcsh), mRNA [NM_026572] |
KLA | .66 |
.67 |
.59 |
.56 |
.40 |
.36 |
.64 |
| ATP | .99 |
1.02 |
1.19 |
1.39 |
1.40 |
.83 |
.82 |
| KLA/ATP | .62 |
.67 |
.73 |
.73 |
.73 |
.55 |
.48 |
|
Glul | |
NM_008131 |
glutamate-ammonia ligase (glutamine synthetase) (Glul), mRNA [NM_008131] |
KLA | .58 |
.54 |
.47 |
.41 |
.30 |
.31 |
.40 |
| ATP | .96 |
.99 |
1.46 |
2.55 |
2.16 |
2.88 |
1.34 |
| KLA/ATP | .57 |
.56 |
.83 |
1.52 |
1.27 |
1.20 |
.97 |
|
Glul | |
X16314 |
gb|M.musculus mRNA for glutamine synthetase. [X16314] |
KLA | .86 |
.95 |
.79 |
.87 |
.78 |
.99 |
.83 |
| ATP | .95 |
1.03 |
1.09 |
1.27 |
1.14 |
1.37 |
1.00 |
| KLA/ATP | .88 |
.97 |
.89 |
1.12 |
1.01 |
1.19 |
.91 |
|
Glyctk | |
NM_174846 |
glycerate kinase (Glyctk), transcript variant 1, mRNA [NM_174846] |
KLA | .98 |
1.05 |
1.12 |
1.07 |
1.13 |
1.16 |
1.11 |
| ATP | 1.04 |
1.07 |
.93 |
.93 |
.72 |
.97 |
1.22 |
| KLA/ATP | 1.02 |
1.02 |
.94 |
.89 |
.82 |
1.00 |
1.26 |
|
Grhpr | |
NM_080289 |
glyoxylate reductase/hydroxypyruvate reductase (Grhpr), mRNA [NM_080289] |
KLA | .82 |
.79 |
.68 |
.60 |
.42 |
.28 |
.56 |
| ATP | .93 |
.99 |
1.24 |
1.33 |
.91 |
.54 |
.71 |
| KLA/ATP | .74 |
.78 |
.84 |
.86 |
.61 |
.31 |
.39 |
|
Hao1 | |
AF104312 |
glycolate oxidase mRNA, complete cds. [AF104312] |
KLA | .85 |
.89 |
.77 |
.82 |
.79 |
.79 |
1.13 |
| ATP | .88 |
.99 |
.95 |
1.90 |
1.11 |
.82 |
1.22 |
| KLA/ATP | .86 |
.81 |
.72 |
1.28 |
1.14 |
.91 |
1.07 |
|
Hao3 | |
NM_019545 |
hydroxyacid oxidase (glycolate oxidase) 3 (Hao3), mRNA [NM_019545] |
KLA | 1.03 |
1.03 |
1.00 |
1.08 |
.97 |
.99 |
.94 |
| ATP | 1.04 |
1.01 |
1.03 |
.97 |
1.07 |
1.01 |
1.01 |
| KLA/ATP | 1.00 |
.97 |
1.03 |
.98 |
1.01 |
1.02 |
1.04 |
|
Hyi | |
NM_026601 |
hydroxypyruvate isomerase homolog (E. coli) (Hyi), mRNA [NM_026601] |
KLA | .37 |
.43 |
.38 |
.50 |
.53 |
.54 |
.87 |
| ATP | .92 |
.68 |
.59 |
.59 |
.52 |
.42 |
.44 |
| KLA/ATP | .41 |
.36 |
.42 |
.33 |
.36 |
.32 |
.34 |
|
Mcee | |
NM_028626 |
methylmalonyl CoA epimerase (Mcee), mRNA [NM_028626] |
KLA | .94 |
.93 |
.88 |
.92 |
.77 |
.71 |
.87 |
| ATP | .93 |
.97 |
1.28 |
1.51 |
1.31 |
.87 |
.80 |
| KLA/ATP | .88 |
.96 |
1.18 |
1.37 |
1.28 |
.95 |
.83 |
|
Mdh1 | |
AK077724 |
8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730556L21 product:unclassifiable, full insert sequence [AK077724] |
KLA | .85 |
.75 |
.69 |
.67 |
.72 |
.81 |
.82 |
| ATP | .93 |
.83 |
.61 |
.59 |
.72 |
.72 |
.88 |
| KLA/ATP | .79 |
.76 |
.67 |
.58 |
.74 |
.74 |
.80 |
|
Mdh1 | |
NM_008618 |
malate dehydrogenase 1, NAD (soluble) (Mdh1), mRNA [NM_008618] |
KLA | .79 |
.72 |
.66 |
.66 |
.52 |
.49 |
.57 |
| ATP | .98 |
1.00 |
1.17 |
1.09 |
.96 |
.70 |
.66 |
| KLA/ATP | .70 |
.73 |
.92 |
.78 |
.76 |
.65 |
.52 |
|
Mdh2 | |
NM_008617 |
malate dehydrogenase 2, NAD (mitochondrial) (Mdh2), nuclear gene encoding mitochondrial protein, mRNA [NM_008617] |
KLA | .90 |
.91 |
.81 |
.86 |
.81 |
.91 |
1.26 |
| ATP | .96 |
.86 |
1.04 |
.80 |
1.01 |
1.36 |
1.33 |
| KLA/ATP | .87 |
.79 |
1.04 |
.71 |
.95 |
1.04 |
.95 |
|
Mm.27395 8 | |
31560783 |
Unknown |
KLA | .84 |
.82 |
.82 |
.88 |
1.05 |
1.14 |
1.07 |
| ATP | 1.36 |
1.47 |
1.11 |
1.14 |
1.07 |
.85 |
.81 |
| KLA/ATP | .97 |
.93 |
.90 |
1.13 |
1.05 |
.99 |
1.01 |
|
Mm.29323 3 | |
118130035 |
Unknown |
KLA | .98 |
1.04 |
.98 |
1.05 |
1.07 |
.97 |
.95 |
| ATP | 1.02 |
1.04 |
1.01 |
1.02 |
1.00 |
1.00 |
1.00 |
| KLA/ATP | 1.03 |
1.00 |
.98 |
.96 |
1.10 |
1.03 |
.98 |
|
Mut | |
X51941 |
gb|Mouse mRNA for methylmalonyl CoA mutase (EC 5.4.99.2) [X51941] |
KLA | .57 |
.56 |
.51 |
.56 |
.55 |
.63 |
.69 |
| ATP | .89 |
.83 |
1.05 |
.71 |
.41 |
.29 |
.88 |
| KLA/ATP | .52 |
.51 |
.62 |
.40 |
.29 |
.23 |
.38 |
|
Pcca | |
NM_144844 |
propionyl-Coenzyme A carboxylase, alpha polypeptide (Pcca), mRNA [NM_144844] |
KLA | 1.00 |
1.07 |
1.11 |
1.16 |
1.07 |
1.01 |
.68 |
| ATP | .90 |
.97 |
1.10 |
1.14 |
.93 |
.53 |
.60 |
| KLA/ATP | .99 |
1.12 |
1.16 |
1.19 |
.84 |
.59 |
.56 |
|
Pccb | |
NM_025835 |
propionyl Coenzyme A carboxylase, beta polypeptide (Pccb), mRNA [NM_025835] |
KLA | .76 |
.77 |
.67 |
.65 |
.45 |
.41 |
.42 |
| ATP | .97 |
1.12 |
.94 |
1.15 |
.90 |
.51 |
.37 |
| KLA/ATP | .83 |
.82 |
.80 |
.88 |
.65 |
.46 |
.28 |
|
Shmt1 | |
NM_009171 |
serine hydroxymethyltransferase 1 (soluble) (Shmt1), mRNA [NM_009171] |
KLA | .85 |
.89 |
.82 |
.83 |
.82 |
.88 |
.83 |
| ATP | .93 |
.81 |
.85 |
.82 |
.85 |
.86 |
.72 |
| KLA/ATP | .81 |
.83 |
.91 |
.86 |
.85 |
.86 |
.72 |
|
Shmt2 | |
NM_028230 |
serine hydroxymethyltransferase 2 (mitochondrial) (Shmt2), nuclear gene encoding mitochondrial protein, mRNA [NM_028230] |
KLA | .82 |
.90 |
.78 |
.63 |
.51 |
.39 |
.63 |
| ATP | 1.04 |
1.21 |
.97 |
1.44 |
1.32 |
.85 |
.64 |
| KLA/ATP | .94 |
.92 |
.62 |
1.01 |
.59 |
.49 |
.32 |
|